BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1837777)

  • 1. Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
    Ragozzino MM; Kuo A; DeGregori J; Kohl N; Ruley HE
    Environ Health Perspect; 1991 Jun; 93():97-103. PubMed ID: 1837777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification.
    Perry ME; Commane M; Stark GR
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8112-6. PubMed ID: 1325647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 proto-oncogene can act as a suppressor of transformation.
    Finlay CA; Hinds PW; Levine AJ
    Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.
    Yu DH; Scorsone K; Hung MC
    Mol Cell Biol; 1991 Mar; 11(3):1745-50. PubMed ID: 1671710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells.
    Cook JL; May DL; Wilson BA; Walker TA
    J Virol; 1989 Aug; 63(8):3408-15. PubMed ID: 2526229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of NIH 3T3 fibroblasts by human c-sis is dependent upon the level of oncogene expression.
    MacArthur LH; Clarke MF; Westin EH
    Mol Carcinog; 1992; 5(4):311-9. PubMed ID: 1323300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
    Ridley AJ; Paterson HF; Noble M; Land H
    EMBO J; 1988 Jun; 7(6):1635-45. PubMed ID: 3049071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus transformation revertant resistant to retransformation by E1 but not by SV40-T and HPV16-E7 oncogenes.
    Sircar S; Horvath J; Roberge D; Diouri M; Weber JM
    Virology; 1992 Nov; 191(1):187-92. PubMed ID: 1413500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperativity of SV40 T antigen and ras in progressive stages of transformation of human fibroblasts.
    White JA; Carter SG; Ozer HL; Boyd AL
    Exp Cell Res; 1992 Nov; 203(1):157-63. PubMed ID: 1330654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence as a mode of tumor suppression.
    Sager R
    Environ Health Perspect; 1991 Jun; 93():59-62. PubMed ID: 1663451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a.
    Kuppuswamy M; Subramanian T; Chinnadurai G
    Oncogene; 1988 Jun; 2(6):613-5. PubMed ID: 2968534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
    Hirakawa T; Ruley HE
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1519-23. PubMed ID: 2830621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.
    Franza BR; Maruyama K; Garrels JI; Ruley HE
    Cell; 1986 Feb; 44(3):409-18. PubMed ID: 3510745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of transforming domains in E1a/myc chimaeras.
    Ralston R
    Nature; 1991 Oct; 353(6347):866-8. PubMed ID: 1834947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes.
    Shalloway D; Johnson PJ; Freed EO; Coulter D; Flood WA
    Mol Cell Biol; 1987 Oct; 7(10):3582-90. PubMed ID: 2446117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.